Pancreatic Cancer Clinical Trials

Showing 201-220 of 1,185 trials

The Cancer of the Pancreas Screening-5 CAPS5)Study

NCT02000089

Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.

Pancreas CancerPeutz-Jeghers Syndrome (PJS)Gene Mutation+2 more

Johns Hopkins University9,000 participantsStarted Jan 2014

New Haven, Connecticut, United States • Baltimore, Maryland, United States • Boston, Massachusetts, United States +6 more locations

RECRUITINGNA

Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma

NCT03704662

Patients are randomized into two arms. Arm A patients will receive Stereotactic Body Radiation Therapy (SBRT) and Arm B patients with receive conventional concurrent chemotherapy and radiation therapy.

Pancreatic Cancer

Medical College of Wisconsin102 participantsStarted Oct 2018

Milwaukee, Wisconsin, United States

The Cancer of the Pancreas Screening-5 CAPS5)Study

Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma

Related Searches

Multidom Remote Monitoring of Patient With Advanced Pancreatic Cancer Treated With Florinox Using the PiCaDo Plateform

Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

A Study of ABTL0812 in Pancreatic Cancer

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer

A Single-Arm Investigator-Initiated Tria (IIT) Evaluating the Safety and Preliminary Efficacy of Autologous Drug-Loaded Neutrophils (NeuMed) in Patients With Unresectable Pancreatic Cancer

Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer

Patient-derived Organoids Drug Screen in Pancreatic Cancer

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer

Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis

AOH1996 for the Treatment of Refractory Solid Tumors

Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer

UCSF PANC Cyst Registry

Pancreatic Disease Burden in Older Adults (1990-2040)

Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors

Development & Clinical Application of K-PaC Registry Version 2.0